1. Search Result
Search Result
Results for "

PPD10558

" in MedChemExpress (MCE) Product Catalog:
製品番号 製品名 Target 研究分野 構造式
  • HY-106281

    PPD 10558

    HMG-CoA Reductase (HMGCR) Metabolic Disease
    Bemfivastatin (PPD 10558) is an orally active HMG-CoA Reductase (HMGCR) inhibitor. Bemfivastatin enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin can be used for research of metabolic disease, such as hypercholesterolemia .
    Bemfivastatin
  • HY-106281A

    PPD 10558 hemicalcium

    HMG-CoA Reductase (HMGCR) Metabolic Disease
    Bemfivastatin (PPD 10558) hemicalcium is an orally active HMG-CoA Reductase (HMGCR) inhibitor. Bemfivastatin hemicalcium enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin hemicalcium can be used for research of metabolic disease, such as hypercholesterolemia .
    Bemfivastatin hemicalcium
  • HY-106281R

    PPD 10558 (Standard)

    Reference Standards HMG-CoA Reductase (HMGCR) Metabolic Disease
    Bemfivastatin (Standard) is the analytical standard of Bemfivastatin (HY-106281). This product is intended for research and analytical applications. Bemfivastatin (PPD 10558) is an orally active HMG-CoA Reductase (HMGCR) inhibitor. Bemfivastatin enhances the activity of liver extraction and reduces blood lipid levels. Bemfivastatin can be used for research of metabolic disease, such as hypercholesterolemia .
    Bemfivastatin (Standard)

オンラインお問い合わせ

入力情報は安全に管理されます. 必須入力項目.

タイトル

 

国或いは地域 *

お名前 *

 

組纖名 *

デパートメント *

     

メールアドレス *

 

製品名 *

製品番号

 

カスタマ需要量 *

電話番号 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
製品番号:
数量:
MCE 日本正規代理店: